Skip to main content
. 2022 Jan 11;12:798474. doi: 10.3389/fimmu.2021.798474

Figure 2.

Figure 2

Association of COL3A1 mutations with immune checkpoint inhibitor (ICI) survival outcome and response. Kaplan–Meier survival analyses and multivariate Cox regression models with confounding factors taken into account were conducted to evaluate the links of COL3A1 mutations with (A, B) overall survival (OS) and (C, D) progression-free survival (PFS). COL3A1 mutations are associated with (E) objective response rate (ORR) and (F) disease control rate (DCR).